Stent and Attention deficit hyperactivity disorder
Summary:
Attention deficit hyperactivity disorder is found among people with Stent, especially for people who are female, 60+ old.
The study analyzes which people have Attention deficit hyperactivity disorder with Stent. It is created by eHealthMe based on reports of 12 people who have Stent from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Stent?
Stent is found to be associated with 573 drugs and 895 conditions by eHealthMe. Check the latest studies of Stent.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 608 drugs and 1,395 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12 people who have Stent and Attention Deficit Hyperactivity Disorder are studied.

Gender of people who have Stent and experienced Attention Deficit Hyperactivity Disorder *:
- female: 72.73 %
- male: 27.27 %
Age of people who have Stent and experienced Attention Deficit Hyperactivity Disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 9.09 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 90.91 %
Common co-existing conditions for these people *:
- Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 9 people, 75.00%
- Acute Myocardial Infarction (acute heart attack): 9 people, 75.00%
- Sleep Disorder: 8 people, 66.67%
- Insomnia (sleeplessness): 7 people, 58.33%
- Initial Insomnia (feeling of inadequate or poor-quality sleep): 7 people, 58.33%
- Cardiac Disorder: 2 people, 16.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
- High Blood Cholesterol: 2 people, 16.67%
- Heart Disease: 1 person, 8.33%
- Adverse Drug Reaction: 1 person, 8.33%
Common drugs taken by these people *:
- Melatonin: 9 people, 75.00%
- Hydroxyzine: 9 people, 75.00%
- Acetylsalicylic Acid: 9 people, 75.00%
- Zolpidem: 7 people, 58.33%
- Brilinta: 3 people, 25.00%
- Xarelto: 1 person, 8.33%
- Metformin: 1 person, 8.33%
- Losartan: 1 person, 8.33%
- Fluoxetine: 1 person, 8.33%
- Crestor: 1 person, 8.33%
Common symptoms for these people *:
- Hypoaesthesia (reduced sense of touch or sensation): 9 people, 75.00%
- Overdose: 9 people, 75.00%
- Disturbance In Attention: 9 people, 75.00%
- Sleep Disorder: 9 people, 75.00%
- Tachyphylaxis (a medical term describing an acute (sudden) decrease in the response to a drug after its administration): 9 people, 75.00%
- Memory Loss: 9 people, 75.00%
- Stable Angina (a constant chest pain): 8 people, 66.67%
- Chest Pain: 7 people, 58.33%
- Drug Ineffective: 5 people, 41.67%
- Sleep Apnea Syndrome: 2 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Attention deficit hyperactivity disorder?
- Check whether Attention deficit hyperactivity disorder is associated with a drug or a conditionRelated publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Stent (23,726 reports)
- Attention deficit hyperactivity disorder (120,340 reports)
All the drugs that are associated with Attention deficit hyperactivity disorder:
- Attention deficit hyperactivity disorder (608 drugs)
All the conditions that are associated with Attention deficit hyperactivity disorder:
- Attention deficit hyperactivity disorder (1,395 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Attention deficit hyperactivity disorder and Stent, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fistula and drugs of ingredients of pazopanib hydrochloride - now
- Carbidopa And Levodopa and Speech Impairment (Adult) for Women aged 60+ - now
- Carbidopa And Levodopa and Slurred Speech for Women aged 60+ - a second ago
- Carbidopa And Levodopa and Language Impairment for Women aged 60+ - a second ago
- Carbidopa And Levodopa and Inability To Speak for Women aged 60+ - a second ago
- Carbidopa And Levodopa and Impairment Of Speech for Women aged 60+ - 2 seconds ago
- Carbidopa And Levodopa and Dysarthria for Women aged 60+ - 2 seconds ago
- Carbidopa And Levodopa and Aphasia for Women aged 60+ - 2 seconds ago
- Carbidopa And Levodopa and Dysphasia for Women aged 60+ - 3 seconds ago
- Abscess Limb and drugs of ingredients of levothyroxine sodium - 5 seconds ago